Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment

Extranodal Hodgkin lymphoma involving the breast is infrequent. Most cases reported in the literature were diagnosed by histology after lumpectomy. We present a Hodgkin lymphoma mimicking inflammatory breast carcinoma in a 57-year-old woman. The diagnosis was performed by fine-needle aspiration (FNA...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleni Thodou, Maria Befani, George Triantafyllidis, Theodosia Choreftaki, George Kanellis, Nikolaos Giannakoulas
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2019/9256807
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564793780731904
author Eleni Thodou
Maria Befani
George Triantafyllidis
Theodosia Choreftaki
George Kanellis
Nikolaos Giannakoulas
author_facet Eleni Thodou
Maria Befani
George Triantafyllidis
Theodosia Choreftaki
George Kanellis
Nikolaos Giannakoulas
author_sort Eleni Thodou
collection DOAJ
description Extranodal Hodgkin lymphoma involving the breast is infrequent. Most cases reported in the literature were diagnosed by histology after lumpectomy. We present a Hodgkin lymphoma mimicking inflammatory breast carcinoma in a 57-year-old woman. The diagnosis was performed by fine-needle aspiration (FNA) of the breast lesion and the axillary lymph nodes with rapid on-site evaluation followed by immunocytochemistry, and it was confirmed by histology. The patient after first-line chemotherapy developed relapse/refractory disease. Salvage chemotherapy regimens were applied with poor results and severe toxicity. Total remission was achieved with monotherapy of brentuximab vedotin, a novel anti-CD30-targeted antibody drug conjugate. This is a unique case of breast HL with misleading clinical presentation initially diagnosed by cytology. FNA as a minimally invasive diagnostic tool was crucial in avoiding unnecessary breast surgery and further delay of chemotherapy. It is also the first report highlighting the importance of this novel immunotherapy in the management of refractory Hodgkin lymphoma with breast involvement.
format Article
id doaj-art-04618951c833410baafd11a3329851c6
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-04618951c833410baafd11a3329851c62025-02-03T01:10:06ZengWileyCase Reports in Hematology2090-65602090-65792019-01-01201910.1155/2019/92568079256807Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel TreatmentEleni Thodou0Maria Befani1George Triantafyllidis2Theodosia Choreftaki3George Kanellis4Nikolaos Giannakoulas5Department of Pathology, Medical School, University of Thessaly, Viopolis, 41500 Larisa, GreeceHematology, Private Practice, 61 Koumoundourou Str., 38221 Volos, GreeceRadiology, Private Practice, 29 Glavani Str., 38221 Volos, GreeceDepartment of Pathology, “G. Genimmatas”, Athens General Hospital, 154 Mesogeion Ave., 11527 Athens, GreeceDepartment of Hematopathology, “Evangelismos”, General Hospital, 45 Ypsilantou Str., 10676 Athens, GreeceDepartment of Hematology, Medical School, University of Thessaly, Viopolis, 41500 Larisa, GreeceExtranodal Hodgkin lymphoma involving the breast is infrequent. Most cases reported in the literature were diagnosed by histology after lumpectomy. We present a Hodgkin lymphoma mimicking inflammatory breast carcinoma in a 57-year-old woman. The diagnosis was performed by fine-needle aspiration (FNA) of the breast lesion and the axillary lymph nodes with rapid on-site evaluation followed by immunocytochemistry, and it was confirmed by histology. The patient after first-line chemotherapy developed relapse/refractory disease. Salvage chemotherapy regimens were applied with poor results and severe toxicity. Total remission was achieved with monotherapy of brentuximab vedotin, a novel anti-CD30-targeted antibody drug conjugate. This is a unique case of breast HL with misleading clinical presentation initially diagnosed by cytology. FNA as a minimally invasive diagnostic tool was crucial in avoiding unnecessary breast surgery and further delay of chemotherapy. It is also the first report highlighting the importance of this novel immunotherapy in the management of refractory Hodgkin lymphoma with breast involvement.http://dx.doi.org/10.1155/2019/9256807
spellingShingle Eleni Thodou
Maria Befani
George Triantafyllidis
Theodosia Choreftaki
George Kanellis
Nikolaos Giannakoulas
Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
Case Reports in Hematology
title Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
title_full Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
title_fullStr Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
title_full_unstemmed Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
title_short Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
title_sort hodgkin lymphoma mimicking inflammatory breast carcinoma a rare case with diagnostic challenge and novel treatment
url http://dx.doi.org/10.1155/2019/9256807
work_keys_str_mv AT elenithodou hodgkinlymphomamimickinginflammatorybreastcarcinomaararecasewithdiagnosticchallengeandnoveltreatment
AT mariabefani hodgkinlymphomamimickinginflammatorybreastcarcinomaararecasewithdiagnosticchallengeandnoveltreatment
AT georgetriantafyllidis hodgkinlymphomamimickinginflammatorybreastcarcinomaararecasewithdiagnosticchallengeandnoveltreatment
AT theodosiachoreftaki hodgkinlymphomamimickinginflammatorybreastcarcinomaararecasewithdiagnosticchallengeandnoveltreatment
AT georgekanellis hodgkinlymphomamimickinginflammatorybreastcarcinomaararecasewithdiagnosticchallengeandnoveltreatment
AT nikolaosgiannakoulas hodgkinlymphomamimickinginflammatorybreastcarcinomaararecasewithdiagnosticchallengeandnoveltreatment